BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23619990)

  • 1. Stronger prognostic power of the CpG island methylator phenotype than methylation of individual genes in neuroblastomas.
    Asada K; Watanabe N; Nakamura Y; Ohira M; Westermann F; Schwab M; Nakagawara A; Ushijima T
    Jpn J Clin Oncol; 2013 Jun; 43(6):641-5. PubMed ID: 23619990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical application of the CpG island methylator phenotype to prognostic diagnosis in neuroblastomas.
    Asada K; Abe M; Ushijima T
    J Hum Genet; 2013 Jul; 58(7):428-33. PubMed ID: 23739128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas.
    Abe M; Ohira M; Kaneda A; Yagi Y; Yamamoto S; Kitano Y; Takato T; Nakagawara A; Ushijima T
    Cancer Res; 2005 Feb; 65(3):828-34. PubMed ID: 15705880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked and independent prognostic significance of the CpG island methylator phenotype in neuroblastomas.
    Abe M; Westermann F; Nakagawara A; Takato T; Schwab M; Ushijima T
    Cancer Lett; 2007 Mar; 247(2):253-8. PubMed ID: 16759796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
    Astuti D; Agathanggelou A; Honorio S; Dallol A; Martinsson T; Kogner P; Cummins C; Neumann HP; Voutilainen R; Dahia P; Eng C; Maher ER; Latif F
    Oncogene; 2001 Nov; 20(51):7573-7. PubMed ID: 11709729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative global and gene-specific promoter methylation in relation to biological properties of neuroblastomas.
    Kiss NB; Kogner P; Johnsen JI; Martinsson T; Larsson C; Geli J
    BMC Med Genet; 2012 Sep; 13():83. PubMed ID: 22984959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of genes targeted by CpG island methylator phenotype in neuroblastomas, and their possible integrative involvement in poor prognosis.
    Abe M; Watanabe N; McDonell N; Takato T; Ohira M; Nakagawara A; Ushijima T
    Oncology; 2008; 74(1-2):50-60. PubMed ID: 18544995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of CpG island hypermethylation of caspase-8 in neuroblastoma using an oligonucleotide array.
    Kamimatsuse A; Matsuura K; Moriya S; Fukuba I; Yamaoka H; Fukuda E; Kamei N; Hiyama K; Sueda T; Hiyama E
    Pediatr Blood Cancer; 2009 Jul; 52(7):777-83. PubMed ID: 19260109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification.
    Misawa A; Inoue J; Sugino Y; Hosoi H; Sugimoto T; Hosoda F; Ohki M; Imoto I; Inazawa J
    Cancer Res; 2005 Nov; 65(22):10233-42. PubMed ID: 16288011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG Island Methylator Phenotype and Methylation of Wnt Pathway Genes Together Predict Survival in Patients with Colorectal Cancer.
    Kim SH; Park KH; Shin SJ; Lee KY; Kim TI; Kim NK; Rha SY; Ahn JB
    Yonsei Med J; 2018 Jul; 59(5):588-594. PubMed ID: 29869456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma.
    Alaminos M; Davalos V; Cheung NK; Gerald WL; Esteller M
    J Natl Cancer Inst; 2004 Aug; 96(16):1208-19. PubMed ID: 15316056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
    Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH
    Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG island methylator phenotype in colorectal cancers: comparison of the new and classic CpG island methylator phenotype marker panels.
    Lee S; Cho NY; Yoo EJ; Kim JH; Kang GH
    Arch Pathol Lab Med; 2008 Oct; 132(10):1657-65. PubMed ID: 18834226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer.
    Nosho K; Shima K; Irahara N; Kure S; Baba Y; Kirkner GJ; Chen L; Gokhale S; Hazra A; Spiegelman D; Giovannucci EL; Jaenisch R; Fuchs CS; Ogino S
    Clin Cancer Res; 2009 Jun; 15(11):3663-71. PubMed ID: 19470733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between the CpG island methylator phenotype and its prognostic significance in primary pulmonary adenocarcinoma.
    Koh YW; Chun SM; Park YS; Song JS; Lee GK; Khang SK; Jang SJ
    Tumour Biol; 2016 Aug; 37(8):10675-84. PubMed ID: 26867769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG island methylator phenotype of myelodysplastic syndrome identified through genome-wide profiling of DNA methylation and gene expression.
    Zhao X; Yang F; Li S; Liu M; Ying S; Jia X; Wang X
    Br J Haematol; 2014 Jun; 165(5):649-58. PubMed ID: 24601943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact on prognosis of the regional distribution of MGMT methylation with respect to the CpG island methylator phenotype and age in glioma patients.
    Mur P; Rodríguez de Lope Á; Díaz-Crespo FJ; Hernández-Iglesias T; Ribalta T; Fiaño C; García JF; Rey JA; Mollejo M; Meléndez B
    J Neurooncol; 2015 May; 122(3):441-50. PubMed ID: 25682093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG island methylator phenotype and its relationship with prognosis in adult acute leukemia patients.
    Fu HY; Wu DS; Zhou HR; Shen JZ
    Hematology; 2014 Sep; 19(6):329-37. PubMed ID: 24164743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach.
    Loh M; Liem N; Vaithilingam A; Lim PL; Sapari NS; Elahi E; Mok ZY; Cheng CL; Yan B; Pang B; Salto-Tellez M; Yong WP; Iacopetta B; Soong R
    BMC Gastroenterol; 2014 Mar; 14():55. PubMed ID: 24674026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location.
    Bae JM; Kim JH; Cho NY; Kim TY; Kang GH
    Br J Cancer; 2013 Aug; 109(4):1004-12. PubMed ID: 23900220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.